Home›Companies›Biotech & Pharma›Memgen

Memgen, Inc.

Updated Oct 29, 2026·Latest SEC filing Dec 10, 2024·Suggest an edit

About Memgen

Memgen is a private company based in Houston, Texas. It has reported $12,982,207 raised in six offerings on Form D since December 2018.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 26, 2024Dec 10, 2024$950,002of $10.0M target2$475KEquityRule 506(b)Form D ↗
Nov 4, 2022Nov 17, 2022amended Jun 30, 2023$624,979of $10.0M target8$78,122EquityRule 506(b)Form D/A ↗1 earlier filing
Nov 30, 2021Dec 13, 2021amended Dec 14, 2021$9,767,223of $10.0M target60$162KEquityRule 506(b)Form D/A ↗1 earlier filing
May 21, 2020Jun 2, 2020amended Jul 10, 2020$575,000of $10.0M target7$82,143Debt, Securities on exerciseRule 506(b)Form D/A ↗2 earlier filings
Sep 10, 2019Sep 23, 2019$350,000of $5.0M target3$116KEquityRule 506(b)Form D ↗
Nov 19, 2018Dec 4, 2018$715,003of $1.9M target10$71,500EquityRule 506(b)Form D ↗
Total, six offerings$12,982,207

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Memgen's Form D filed Dec 10, 2024.

PB
MC
Mark Cantwell
Executive officer
RC
Robert Coates
Executive officer and director
SW
GB
Gregory Brown
Executive officer and director
CL
Casey Logan
Director
JP
John Poulos
Director

Earlier filings also listed Kevin Coveney (cfo, last listed Dec 2021).

Sources

  1. SECMemgen, Inc. Form D, filed Nov 17, 2022
  2. SECMemgen, Inc. Form D, filed Dec 13, 2021
  3. SECMemgen, Inc. Form D/A, filed Jul 10, 2020
  4. SECMemgen, Inc. Form D, filed Jun 2, 2020
  5. SECMemgen, Inc. filing history